Servicewomen and Veterans Menopause Research Act
- Bill Number
- S. 1320
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Armed Forces and National Security
- Status
- Introduced
- Latest Action
- 2025-12-02: Placed on Senate Legislative Calendar under General Orders. Calendar No. 275.
- Last Updated
- 2026-06-27T21:05:13Z
AI-Generated Summary
Purpose
The Servicewomen and Veterans Menopause Research Act (S. 1320) aims to improve understanding and care for menopause, perimenopause, and mid-life women's health among active-duty servicewomen and veterans. It directs the Department of Defense (DoD) and the Department of Veterans Affairs (VA) to assess existing research, identify gaps, and develop plans to enhance training, treatments, and future studies, recognizing these life stages as normal aging processes that can affect health and military readiness.
Key Provisions
- Definitions: The bill defines key terms for clarity, including:
- Covered provider: A healthcare worker employed by DoD or VA.
- Menopause: The permanent end of menstrual periods, a natural part of aging, not a disease.
- Mid-life: Roughly ages 35–65, overlapping with menopausal changes and the start of chronic conditions like osteoporosis or heart disease.
- Perimenopause: The transition period when estrogen levels fluctuate, leading to irregular periods.
- Postmenopausal: The lifelong stage after 12 months without periods, with higher risks for bone and heart issues.
- Evaluation of Research (Section 3): DoD's Secretary, in coordination with VA's Secretary, must review:
- Completed and ongoing studies on menopause, perimenopause, or mid-life health in servicewomen and veterans.
- Knowledge gaps, such as effective treatments (hormone-based or non-hormone), links between military service (e.g., combat exposure to burn pits, chemicals, or PFAS—forever chemicals) and symptoms, and mental health effects.
- Availability and use of training for providers on managing these conditions.
- Access to and use of treatments for affected women.
- Report and Strategic Plan (Section 3): Within 180 days of enactment, each Secretary must submit a congressional report including evaluation findings, recommendations to improve provider training, and a plan to address research gaps and prioritize new studies on treatments.
- Nonduplication Clause (Section 3): Efforts must avoid overlap and build on, rather than replace, existing work by the Department of Health and Human Services (HHS).
- Sense of Congress (Section 4): Encourages DoD and VA to actively pursue additional research on these topics for servicewomen and veterans.
Significant Changes to Existing Law
This bill introduces new mandates for DoD and VA to systematically evaluate and plan research on menopause-related issues specific to military service and veteran populations. It does not amend prior laws but adds requirements for coordinated assessments, reporting, and strategic planning, filling a gap in targeted federal health initiatives for women's mid-life transitions in these groups.
Potential Impacts
- Government Agencies: DoD and VA will face increased responsibilities for research coordination, reporting to Congress, and provider training, potentially requiring resource allocation but also fostering better integration with HHS efforts. This could lead to more evidence-based healthcare policies.
- Citizens (Servicewomen and Veterans): Women in the military or receiving VA care may benefit from improved access to treatments, better-informed providers, and research addressing service-related factors (e.g., toxin exposure), potentially reducing health disparities and enhancing quality of life during mid-life.
- International Relations: No direct impacts; the focus is domestic military and veteran health.
Main Stakeholders Affected
- Servicewomen and Female Veterans: Primary beneficiaries, as the bill targets their unique health needs influenced by military service.
- DoD and VA: Responsible for implementation, including research, training, and reporting; covered providers within these agencies will need updated professional development.
- Congress: Receives reports and plans, enabling oversight and potential future funding or legislation.
- HHS: Indirectly involved through nonduplication requirements, ensuring complementary efforts in broader women's health research.
Notable Legal, Constitutional, or Political Implications
- Legal: The bill's directives are administrative, relying on executive branch coordination without creating new entitlements or liabilities. It emphasizes evidence-based approaches, potentially supporting future VA benefit claims related to service-connected menopause symptoms.
- Constitutional: Aligns with Congress's authority over military affairs and veteran benefits (Article I, Section 8), with no apparent conflicts to individual rights or federalism.
- Political: Bipartisan sponsorship (from senators across parties) highlights broad support for women's health in national security contexts, signaling a push for gender-specific research in federal programs without partisan controversy. It may encourage similar initiatives in civilian healthcare.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (10)
Sen. Ernst, Joni [R-IA], Sen. Justice, James C. [R-WV], Sen. Ossoff, Jon [D-GA], Sen. Cassidy, Bill [R-LA], Sen. Shaheen, Jeanne [D-NH], Sen. Gillibrand, Kirsten E. [D-NY], Sen. Hickenlooper, John W. [D-CO], Sen. Klobuchar, Amy [D-MN], Sen. Moran, Jerry [R-KS], Sen. King, Angus S., Jr. [I-ME]
Recent Actions
- 2025-12-02: Placed on Senate Legislative Calendar under General Orders. Calendar No. 275.
- 2025-12-02: Committee on Veterans' Affairs. Reported by Senator Moran with amendments. Without written report.
- 2025-12-02: Committee on Veterans' Affairs. Reported by Senator Moran with amendments. Without written report.
- 2025-07-30: Committee on Veterans' Affairs. Ordered to be reported with amendments favorably.
- 2025-05-21: Committee on Veterans' Affairs. Hearings held. Hearings printed: S.Hrg. 119-86.
- 2025-04-08: Read twice and referred to the Committee on Veterans' Affairs.
- 2025-04-08: Introduced in Senate
Bill Versions
- Servicewomen and Veterans Menopause Research Act — issued 2025-04-08 — PDF (6 pages)
- Servicewomen and Veterans Menopause Research Act — issued 2025-12-02 — PDF (8 pages)